Pian L, Wen X, Kang L, Li Z, Nie Y, Du Z, et al
Structure Therapeutics
The Center for Medicine in the Public Interest has published a handout to dispel myths about mass compounding
CrossRef Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis Marie Rhee, Joonyub Lee, Cheol Woon Jung, Jinsung Yang, Won Gun Choi, Young-Hye You, Heon-Seok Park, Eun Young Lee, Eun Kyung Lee, Sung Won Kwon, Young-Bum Kim, Seung-Hwan Lee Molecular Therapy.2026;[Epub] CrossRef Does Tuberculosis Leave a Thromboinflammatory Memory After Cure
Importantly, the FDA has identified and communicated other potential cancer concerns with this drug class
Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service